Integrating Telemedicine to Help Diagnose & Manage Severe Eosinophilic Asthma

Host: Matt Birnholz, MD <br> Guest: Kevin Fussell, MD <br> <p>Up to one in 10 patients with asthma have severe disease, and of those patients, up to 1.3 million have severe uncontrolled asthma.^1-3 Since severe asthma has been associated with reduced lung function and poor outcomes.^4,5 Dr Kevin Fussell is here to talk about how a treatment option may help patients with severe eosinophilic asthma as well as how we can use telemedicine to help manage and diagnose them.</p> <ol> <li>Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. <em>Eur Respir J.</em> 2014;43(2):343-373.</li> <li>Hankin CS, Bronstone A, Wang Z, Small MB, Buck P. Estimated prevalence and economic burden of severe, uncontrolled asthma in the United States. <em>J Allergy Clin Immunol.</em> 2013;131(2):AB126.</li> <li>Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed August 22, 2020.</li> <li>Newby C, Agbetile J, Hargadon, B, et al. Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma. <em>J Allergy Clin Immunol.</em> 2014;134(2):287-294.</li> <li>Global Initiative for Asthma. Difficult-to-treat and severe asthma in adolescent and adult patients 2019. Available from:https://ginasthma.org/wp-content/uploads/2019/04/GINA-Severe-asthma-Pocket-Guide-v2.0-wms-1.pdf. Accessed November 1, 2020.</li> </ol> <p style="text-align: right;"> <span>©2020 AstraZeneca. All rights reserved. US-34513 Last Updated 11/20</span></p> ...